JP2015502179A - バイオフィルムを予防および処理するための組成物および方法 - Google Patents

バイオフィルムを予防および処理するための組成物および方法 Download PDF

Info

Publication number
JP2015502179A
JP2015502179A JP2014515857A JP2014515857A JP2015502179A JP 2015502179 A JP2015502179 A JP 2015502179A JP 2014515857 A JP2014515857 A JP 2014515857A JP 2014515857 A JP2014515857 A JP 2014515857A JP 2015502179 A JP2015502179 A JP 2015502179A
Authority
JP
Japan
Prior art keywords
trehalose
enzyme
biofilm
group
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014515857A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015502179A5 (https=
Inventor
エー． イヴァノーヴァ、スヴェトラーナ
エー． イヴァノーヴァ、スヴェトラーナ
ダブリュー． デービス、デニス
ダブリュー． デービス、デニス
ダブリュー． アレンズ、ブラッド
ダブリュー． アレンズ、ブラッド
ケー． コネラン、トーマス
ケー． コネラン、トーマス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2015502179A publication Critical patent/JP2015502179A/ja
Publication of JP2015502179A5 publication Critical patent/JP2015502179A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01028—Alpha,alpha-trehalase (3.2.1.28)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00—Metal working
    • Y10T29/49—Method of mechanical manufacture
    • Y10T29/49826—Assembling or joining

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Agronomy & Crop Science (AREA)
  • Oncology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Pest Control & Pesticides (AREA)
  • Ophthalmology & Optometry (AREA)
JP2014515857A 2011-06-13 2012-06-01 バイオフィルムを予防および処理するための組成物および方法 Pending JP2015502179A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161520654P 2011-06-13 2011-06-13
US61/520,654 2011-06-13
US13/481,787 2012-05-26
US13/481,787 US20120315260A1 (en) 2011-06-13 2012-05-26 Compositions and Methods to Prevent and Treat Biofilms
PCT/US2012/040408 WO2012173796A2 (en) 2011-06-13 2012-06-01 Compositions and methods to prevent and treat biofilms

Publications (2)

Publication Number Publication Date
JP2015502179A true JP2015502179A (ja) 2015-01-22
JP2015502179A5 JP2015502179A5 (https=) 2015-07-16

Family

ID=47293375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014515857A Pending JP2015502179A (ja) 2011-06-13 2012-06-01 バイオフィルムを予防および処理するための組成物および方法

Country Status (5)

Country Link
US (1) US20120315260A1 (https=)
EP (1) EP2717926B1 (https=)
JP (1) JP2015502179A (https=)
DK (1) DK2717926T3 (https=)
WO (1) WO2012173796A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180064372A (ko) * 2015-08-18 2018-06-14 위스콘신 얼럼나이 리서어치 화운데이션 의료 장치 포장 필름으로부터의 ClO2 가스의 방출

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548121B2 (ja) 2007-05-14 2014-07-16 リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク バイオフィルム中の細菌細胞における生理学的分散応答の誘導
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US10420822B2 (en) 2011-06-13 2019-09-24 Ziolase, Llc Compositions and methods to prevent and treat biofilms
US9549904B2 (en) 2012-06-06 2017-01-24 Thomas Bryan Method of destroying bacterial biofilm using sterile intravenous or intracavernous glycerin
US9480669B2 (en) 2015-01-06 2016-11-01 The Regents Of The University Of California Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
DE102013201883B4 (de) * 2013-02-05 2025-11-20 Zyfoma Gmbh Verwendung einer wässrigen Lösung einer Säure als Behandlungsflüssigkeit zur Reinigung eines Implantat-Teils
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
EP2803372A1 (en) 2013-05-16 2014-11-19 Universiteit Twente Process for the preparation of an object supporting a lipid bilayer
US20180044628A1 (en) * 2015-03-13 2018-02-15 The Regents Of The University Of California Method for Biofilm Control and Treatment
WO2017100927A1 (en) 2015-12-15 2017-06-22 Neovasc Tiara Inc. Transseptal delivery system
JP7006940B2 (ja) 2016-01-29 2022-01-24 ニオバスク ティアラ インコーポレイテッド 流出の閉塞を回避するための人工弁
JP7249149B2 (ja) * 2016-05-12 2023-03-30 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア バイオフィルムの堆積および産生を阻害するための組成物および方法
WO2018209345A1 (en) * 2017-05-12 2018-11-15 The Trustees Of The University Of Pennsylvania Compositions and methods for inhibiting biofilm deposition and production
WO2018090148A1 (en) 2016-11-21 2018-05-24 Neovasc Tiara Inc. Methods and systems for rapid retraction of a transcatheter heart valve delivery system
BR112019018738A2 (pt) * 2017-03-10 2020-04-07 Biohm Health Llc composições e métodos para promoção de uma flora microbiana saudável em um mamífero
US11382885B2 (en) 2017-06-07 2022-07-12 The Regents Of The University Of California Compositions for treating fungal and bacterial biofilms and methods of using the same
CN111263622A (zh) 2017-08-25 2020-06-09 内奥瓦斯克迪亚拉公司 顺序展开的经导管二尖瓣假体
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
AU2019374743B2 (en) 2018-11-08 2022-03-03 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
US12226386B2 (en) 2018-12-03 2025-02-18 The Regents Of The University Of California Compositions and methods for treating biofilms
JP7430732B2 (ja) 2019-03-08 2024-02-13 ニオバスク ティアラ インコーポレイテッド 回収可能補綴物送達システム
EP3946163B1 (en) 2019-04-01 2025-08-20 Neovasc Tiara Inc. Controllably deployable prosthetic valve
US11491006B2 (en) 2019-04-10 2022-11-08 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
EP4729110A2 (en) 2019-05-20 2026-04-22 Neovasc Tiara Inc. Introducer with hemostasis mechanism
WO2020257643A1 (en) 2019-06-20 2020-12-24 Neovasc Tiara Inc. Low profile prosthetic mitral valve
CN110538314B (zh) * 2019-09-28 2024-09-13 上海泌码生命科学有限公司 用于杀灭已形成生物膜的铜绿假单胞菌的抗菌肽组合物
CN113769148B (zh) * 2021-09-27 2023-03-21 中国科学院微生物研究所 PslG蛋白在隐形眼镜护理液中的应用
US12109176B1 (en) 2023-04-20 2024-10-08 Thomas Bryan Effect of glycerol on biofilm forming bacteria and fungi that changes the microbes sensitivity to pro and anti-biofilm non-toxic, non-bonded plasma amino acids and amino acid derivatives

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000508175A (ja) * 1996-04-10 2000-07-04 メルク エンド カンパニー インコーポレーテッド 組み換え酵母用培地を改良する方法
JP2001519404A (ja) * 1997-10-16 2001-10-23 ファーマカル、バイオテクノロジーズ、インコーポレーテッド 細菌のコロニー形成を抑制する組成物
JP2003061651A (ja) * 2001-08-21 2003-03-04 Toyo Univ 耐熱性トレハラーゼと、その製造法
JP2009542618A (ja) * 2006-06-30 2009-12-03 インスティティ・パスツール バイオフィルム阻害のための細菌の多糖体の使用
JP2010527335A (ja) * 2007-05-18 2010-08-12 ケーン バイオテク インコーポレイテッド 抗菌組成物およびそれらの使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0751063A (ja) * 1993-06-11 1995-02-28 Kirin Brewery Co Ltd 逆反応性を有するトレハラーゼ、およびα，α−トレハロースの製造方法
JP3659985B2 (ja) * 1993-12-28 2005-06-15 三栄源エフ・エフ・アイ株式会社 トレハラーゼ及び該酵素を用いた糖類の製法
NZ306445A (en) * 1995-04-07 1999-02-25 Betzdearborn Inc Exopolysaccharide degrading enzyme and its use in the treatment of aqueous systems
IN1997CH00924A (en) * 1996-05-03 2005-03-04 Syngenta Mogen Bv Regulating metabolism by modifying the level of trehalose-6-phosphate
US6759040B1 (en) * 1997-09-12 2004-07-06 University Of Maryland, College Park Preparation and use of biofilm-degrading, multiple-specificity, hydrolytic enzyme mixtures
US20020022005A1 (en) * 1997-10-16 2002-02-21 Budny John A. Compositions for treating cystic fibrosis
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
EP1081232A1 (en) * 1999-08-30 2001-03-07 K.U. Leuven Research & Development Novel target for antifungals
EP1796687A2 (en) * 2004-09-14 2007-06-20 Elixir Pharmaceuticals, Inc. Combination therapy for controlled carbohydrate digestion
PL2254591T3 (pl) * 2008-02-08 2018-01-31 Prothera Inc Inhibicja i leczenie biofilmów żołądkowo-jelitowych
WO2011063394A2 (en) * 2009-11-23 2011-05-26 Olmstead Stephen F Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000508175A (ja) * 1996-04-10 2000-07-04 メルク エンド カンパニー インコーポレーテッド 組み換え酵母用培地を改良する方法
JP2001519404A (ja) * 1997-10-16 2001-10-23 ファーマカル、バイオテクノロジーズ、インコーポレーテッド 細菌のコロニー形成を抑制する組成物
JP2003061651A (ja) * 2001-08-21 2003-03-04 Toyo Univ 耐熱性トレハラーゼと、その製造法
JP2009542618A (ja) * 2006-06-30 2009-12-03 インスティティ・パスツール バイオフィルム阻害のための細菌の多糖体の使用
JP2010527335A (ja) * 2007-05-18 2010-08-12 ケーン バイオテク インコーポレイテッド 抗菌組成物およびそれらの使用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180064372A (ko) * 2015-08-18 2018-06-14 위스콘신 얼럼나이 리서어치 화운데이션 의료 장치 포장 필름으로부터의 ClO2 가스의 방출
KR102554778B1 (ko) 2015-08-18 2023-07-11 위스콘신 얼럼나이 리서어치 화운데이션 의료 장치 포장 필름으로부터의 ClO2 가스의 방출

Also Published As

Publication number Publication date
US20120315260A1 (en) 2012-12-13
EP2717926A2 (en) 2014-04-16
WO2012173796A3 (en) 2013-05-02
EP2717926A4 (en) 2014-12-31
EP2717926B1 (en) 2017-05-24
WO2012173796A2 (en) 2012-12-20
DK2717926T3 (en) 2017-09-18

Similar Documents

Publication Publication Date Title
EP2717926B1 (en) Compositions and methods to prevent and treat biofilms
US10758596B2 (en) Compositions and methods to prevent and treat biofilms
CA3088187A1 (en) Compositions and methods to prevent and treat biofilms
US20200078448A1 (en) Compositions and methods to prevent and treat biofilms
Kokare et al. Biofilm: Importance and applications
ES2951464T3 (es) Composiciones antimicrobianas
Jain et al. Biofilms—a microbial life perspective: a critical review
Cos et al. Biofilms: an extra hurdle for effective antimicrobial therapy
Tolker‐Nielsen Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities
Vani et al. A narrative review on bacterial biofilm: Its formation, clinical aspects and inhibition strategies
EP2236594B1 (en) Method for removing biofilms
Walker et al. A review of biofilms and their role in microbial contamination of dental unit water systems (DUWS)
T. Rybtke et al. The implication of Pseudomonas aeruginosa biofilms in infections
KR102196205B1 (ko) 무독화 lps 및 lta를 조합으로 포함하는 생물막 형성 방지 또는 저해용 조성물
Percival et al. An introduction to the world of microbiology and biofilmology
ES2443643T3 (es) Una nueva estrategia no antibiótica frente a infecciones de OGIP basada en un cereal activado
Liaqat et al. Biofilm, dental unit water line and its control
Fonseca Biofilms in wounds: An unsolved problem?
Di Filippo et al. The role of biofilms in endodontic treatment failure.
Garner The effects of quorum sensing molecules on Streptococcus mutans biofilm
Whiteley et al. Biofilms that impact on human health
KR102714856B1 (ko) 라피노스와 6-gingerol의 혼합물을 유효성분으로 포함하는 바이오필름 형성 억제용 조성물 및 이를 이용한 바이오필름 형성 억제 방법
Atanasković et al. Enzyme-based strategies for inhibiting medically relevant biofilms: applications in healthcare and food safety
Kao et al. Biofilm disease and otitis
THALLINGER Functionalization of catheters with antimicrobial enzymes

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141016

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150528

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150528

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160225

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160301

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160521

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160721

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20161101